276 related articles for article (PubMed ID: 11217502)
1. [Strategy for early diagnosis of lung involvement in systemic scleroderma].
Diot E; Valat C; Boissinot E; Giraudeau B; Asquier E; Guilmot JL; Lemarié E; Diot P
Rev Mal Respir; 2000 Dec; 17(6):1073-80. PubMed ID: 11217502
[TBL] [Abstract][Full Text] [Related]
2. Non-invasive diagnostic and functional evaluation of cardiac and pulmonary involvement in systemic sclerosis.
Sergiacomi G; De Nardo D; Capria A; Manenti G; Fabiano S; Borzi M; De Sanctis G; Konda D; Sperandio M; Schillaci O; Masala S; Simonetti G; Fontana L
In Vivo; 2004; 18(2):229-35. PubMed ID: 15113051
[TBL] [Abstract][Full Text] [Related]
3. [Cardiac and pulmonary involvement in scleroderma].
Launay D; Hachulla E
Rev Prat; 2002 Nov; 52(17):1901-7. PubMed ID: 12532867
[TBL] [Abstract][Full Text] [Related]
4. Systemic sclerosis/scleroderma: a treatable multisystem disease.
Hinchcliff M; Varga J
Am Fam Physician; 2008 Oct; 78(8):961-8. PubMed ID: 18953973
[TBL] [Abstract][Full Text] [Related]
5. [Lung impairment in systemic sclerosis].
Knoop H; Arinir U; Kreuter A; Walther JW; Schultze-Werninghaus G; Rohde G
Pneumologie; 2009 Sep; 63(9):497-507. PubMed ID: 19708006
[TBL] [Abstract][Full Text] [Related]
6. [Various aspects of the differential diagnosis of a pulmonary syndrome in systemic scleroderma and chronic aspecific lung diseases].
Doroshenko IuA; Bagirova VV; Savinova NA
Ter Arkh; 1987; 59(4):92-7. PubMed ID: 3590012
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary function tests.
Behr J; Furst DE
Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v65-7. PubMed ID: 18784151
[TBL] [Abstract][Full Text] [Related]
8. Management of scleroderma in a New Zealand tertiary rheumatology centre: emphasis on pulmonary complications.
Ng K; Gow P
N Z Med J; 2007 May; 120(1254):U2537. PubMed ID: 17515941
[TBL] [Abstract][Full Text] [Related]
9. Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension.
Williams MH; Handler CE; Akram R; Smith CJ; Das C; Smee J; Nair D; Denton CP; Black CM; Coghlan JG
Eur Heart J; 2006 Jun; 27(12):1485-94. PubMed ID: 16682379
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatment.
Proudman SM; Stevens WM; Sahhar J; Celermajer D
Intern Med J; 2007 Jul; 37(7):485-94. PubMed ID: 17547726
[TBL] [Abstract][Full Text] [Related]
11. Lung involvement in systemic sclerosis.
Silver RM; Miller KS
Rheum Dis Clin North Am; 1990 Feb; 16(1):199-216. PubMed ID: 2406808
[TBL] [Abstract][Full Text] [Related]
12. Associations of right ventricular myocardial function with skin and pulmonary involvement in asymptomatic patients with systemic sclerosis.
D'Andrea A; Bellissimo S; Scotto di Uccio F; Vigorito F; Moscato F; Tozzi N; Di Donato M; Citro R; Stisi S; Scherillo M
Ital Heart J; 2004 Nov; 5(11):831-9. PubMed ID: 15633438
[TBL] [Abstract][Full Text] [Related]
13. The complexity of managing systemic sclerosis: screening and diagnosis.
Matucci-Cerinic M; Steen V; Nash P; Hachulla E
Rheumatology (Oxford); 2009 Jun; 48 Suppl 3():iii8-13. PubMed ID: 19487228
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the functional parameters in scleroderma cases with pulmonary involvement.
Celebi Sözener Z; Karabıyıkoğlu G; Düzgün N
Tuberk Toraks; 2010; 58(3):235-41. PubMed ID: 21038133
[TBL] [Abstract][Full Text] [Related]
15. Nailfold capillary microscopy can suggest pulmonary disease activity in systemic sclerosis.
Bredemeier M; Xavier RM; Capobianco KG; Restelli VG; Rohde LE; Pinotti AF; Pitrez EH; Vieira MV; Fontoura MA; Ludwig DH; Brenol JC
J Rheumatol; 2004 Feb; 31(2):286-94. PubMed ID: 14760798
[TBL] [Abstract][Full Text] [Related]
16. Cardiac complications of systemic sclerosis: recent progress in diagnosis.
Boueiz A; Mathai SC; Hummers LK; Hassoun PM
Curr Opin Rheumatol; 2010 Nov; 22(6):696-703. PubMed ID: 20657283
[TBL] [Abstract][Full Text] [Related]
17. Dyspnea due to pulmonary hypertension and interstitial lung disease in scleroderma: room for improvement in diagnosis and management.
Racz H; Mehta S
J Rheumatol; 2006 Sep; 33(9):1723-5. PubMed ID: 16960934
[No Abstract] [Full Text] [Related]
18. Survival in patients with pulmonary arterial hypertension associated with systemic sclerosis from a Swedish single centre: prognosis still poor and prediction difficult.
Hesselstrand R; Wildt M; Ekmehag B; Wuttge DM; Scheja A
Scand J Rheumatol; 2011 Mar; 40(2):127-32. PubMed ID: 20858146
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary complications: one of the most challenging complications of systemic sclerosis.
Wells AU; Steen V; Valentini G
Rheumatology (Oxford); 2009 Jun; 48 Suppl 3():iii40-4. PubMed ID: 19487223
[TBL] [Abstract][Full Text] [Related]
20. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
Garin MC; Highland KB; Silver RM; Strange C
J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
